Correlation Between Uniper SE and Viridian Therapeutics
Can any of the company-specific risk be diversified away by investing in both Uniper SE and Viridian Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Uniper SE and Viridian Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Uniper SE and Viridian Therapeutics, you can compare the effects of market volatilities on Uniper SE and Viridian Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Uniper SE with a short position of Viridian Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Uniper SE and Viridian Therapeutics.
Diversification Opportunities for Uniper SE and Viridian Therapeutics
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Uniper and Viridian is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Uniper SE and Viridian Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viridian Therapeutics and Uniper SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Uniper SE are associated (or correlated) with Viridian Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viridian Therapeutics has no effect on the direction of Uniper SE i.e., Uniper SE and Viridian Therapeutics go up and down completely randomly.
Pair Corralation between Uniper SE and Viridian Therapeutics
Assuming the 90 days trading horizon Uniper SE is expected to under-perform the Viridian Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Uniper SE is 1.75 times less risky than Viridian Therapeutics. The stock trades about -0.06 of its potential returns per unit of risk. The Viridian Therapeutics is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 2,211 in Viridian Therapeutics on September 2, 2024 and sell it today you would lose (29.00) from holding Viridian Therapeutics or give up 1.31% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Uniper SE vs. Viridian Therapeutics
Performance |
| Timeline |
| Uniper SE |
| Viridian Therapeutics |
Uniper SE and Viridian Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Uniper SE and Viridian Therapeutics
The main advantage of trading using opposite Uniper SE and Viridian Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Uniper SE position performs unexpectedly, Viridian Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viridian Therapeutics will offset losses from the drop in Viridian Therapeutics' long position.| Uniper SE vs. Roebuck Food Group | Uniper SE vs. Sealed Air Corp | Uniper SE vs. Hilton Food Group | Uniper SE vs. Ryanair Holdings plc |
| Viridian Therapeutics vs. Uniper SE | Viridian Therapeutics vs. Mulberry Group PLC | Viridian Therapeutics vs. London Security Plc | Viridian Therapeutics vs. Triad Group PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |